Takeda Development Center Americas, Inc, Cambridge, MA, USA; Duke University Medical Center, Durham, NC, USA.
Signant Health, Blue Bell, PA, USA.
Value Health. 2022 Jul;25(7):1090-1098. doi: 10.1016/j.jval.2022.02.012. Epub 2022 Apr 2.
Although best practices from electronic patient-reported outcome (PRO) measures are transferable, the migration of clinician-reported outcome (ClinRO) assessments to electronic modes requires recommendations that address their unique properties, such as the user (eg, clinician), and complexity associated with programming of clinical content. Faithful migration remains essential to ensuring that the content and psychometric properties of the original scale (ie, validated reference) are preserved, such that clinicians completing the ClinRO assessments interpret and respond to the items the same way regardless of data collection mode. The authors present a framework for how to "faithfully" migrate electronic ClinRO assessments for successful deployment in clinical trials.
Critical Path Institute's Electronic PRO Consortium and PRO Consortium convened a consensus panel of representatives from member firms to develop recommendations for electronic migration and implementation of ClinRO assessments in clinical trials based on industry standards, regulatory guidelines where available, and relevant literature. The recommendations were reviewed and approved by all member firms from both consortia.
Standard, minimal electronic modifications for ClinRO assessments are described. This article also outlines implementation steps, including planning, startup, electronic clinical outcome assessment system development, training, and deployment. The consensus panel proposes that functional clinical testing by a clinician or clinical outcome assessment expert, as well as copyright holder review of screenshots (if possible) are sufficient to support minimal modifications during migration. Additional evidence generation is proposed for modifications that deviate significantly from the validated reference.
尽管电子患者报告结局(PRO)测量的最佳实践是可转移的,但临床医生报告结局(ClinRO)评估向电子模式的迁移需要提出一些建议,这些建议需要考虑到其独特的属性,例如用户(例如,临床医生),以及与临床内容编程相关的复杂性。忠实迁移仍然是确保原始量表(即经过验证的参考量表)的内容和心理测量特性得以保留的关键,以便完成 ClinRO 评估的临床医生以相同的方式解释和响应项目,而不管数据收集模式如何。作者提出了一个框架,说明如何“忠实地”迁移电子 ClinRO 评估,以成功部署在临床试验中。
关键路径研究所的电子 PRO 联盟和 PRO 联盟召集了一个由成员公司代表组成的共识小组,根据行业标准、可用的监管指南和相关文献,为电子迁移和临床试验中 ClinRO 评估的实施制定建议。所有成员公司都对这些建议进行了审查和批准。
描述了 ClinRO 评估的标准、最小电子修改。本文还概述了实施步骤,包括规划、启动、电子临床结局评估系统开发、培训和部署。共识小组建议,临床医生或临床结局评估专家进行功能临床测试,以及版权持有人对屏幕截图进行审查(如果可能),足以支持迁移过程中的最小修改。对于与经过验证的参考量表有明显偏差的修改,建议生成更多的证据。